Fereidoun Mahboudi - Concepedia

Author

Fereidoun Mahboudi

Also Known As

F Mahboudi, F. MAHBOUDI, F. Mahboudi, F. Mahboudi ., Fereidoun Mahboudi, Feridoun Mahboudi, Mohsen Abolhassa, Mahboudi F

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Pasteur Institute of Iran Biotechnology Research Center Tarbiat Modares University Tehran University of Medical Sciences Islamic Azad University, East Tehran Branch

About

Fereidoun Mahboudi is an author at Pasteur Institute of Iran specializing in medicine, immunology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	630
2	Engineering	6	6	199
3	Natural Sciences	4	4	87
4	Public Health	4	4	131
5	Biochemistry	2	2	103

Fereidoun Mahboudi

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumor-directed oligoclonal T cell therapy Fatemeh Rahimi Jamnani, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar, Biochimica et Biophysica Acta (BBA) - General Subjects Cell TherapyTumor ImmunologyT CellsImmunologyAntigen Processing	2013	89
Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents Zahra Sharifzadeh, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar, Cancer Letters T CellsImmunoengineeringImmunologyAntigen ProcessingAutoimmunity	2012	74
Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody Fatemeh Torkashvand, Behrouz Vaziri, Shayan Maleknia, PLoS ONE EngineeringAmino AcidsGlycobiologyCell CultureQuality Targets	2015	69
<b><i>Leishmaniasis recidivans</i> among school children in Bam, South‐east Iran, 1994–2006</b> Iraj Sharifi, Alireza Fekri, Mohammad Reza Aflatoonian, International Journal of Dermatology	2010	58
Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells Fatemeh Rahimi Jamnani, Fatemeh Rahbarizadeh, Mohammad Ali Shokrgozar, Experimental Cell Research Tumor BiologyProtein NanoparticlesTumor TargetingEpitope-distinct Oligoclonal NanobodiesRadiation Oncology	2012	53
A metabolic network-based approach for developing feeding strategies for CHO cells to increase monoclonal antibody production Hamideh Fouladiha, Sayed‐Amir Marashi, Fatemeh Torkashvand, Bioprocess and Biosystems Engineering NutritionEngineeringImmunologyMonoclonal Antibody ProductionMetabolic Network-based Approach	2020	51
Cytokine Gene Expression in Healing and Non‐Healing Cases of Cutaneous Leishmaniasis in Response to <i>In vitro</i> Stimulation with Recombinant gp63 Using Semi‐Quantitative RT–PCR Gholamreza Habibi, Ali Khamesipour, W. Robert McMaster, Scandinavian Journal of Immunology	2001	47
Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: A preliminary report Samad Amini‐Bavil‐Olyaee, Seyed Moayed Alavian, Ahmad Adeli, Journal of Medical Virology Haplotype DeterminationHepatic DisordersCore PromoterViral HepatitisGenetic Epidemiology	2006	42
Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients Golnaz Bahramali, Majid Sadeghizadeh, Samad Amini‐Bavil‐Olyaee, World Journal of Gastroenterology	2008	41
Proteome modifications of juvenile beluga (Huso huso) brain as an effect of dietary methylmercury Saeed Keyvanshokooh, Behrouz Vaziri, Ahmad Gharaei, Comparative Biochemistry and Physiology Part D Genomics and Proteomics Animal PhysiologyNutritionBiologyHuso HusoBrain Development	2009	40

Page 1